Literature DB >> 21431935

Generic and therapeutic substitution: ethics meets health economics.

Steven Simoens.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21431935     DOI： 10.1007/s11096-011-9500-7

Source DB:  PubMed          Journal:  Int J Clin Pharm


× No keyword cloud information.
  6 in total

Review 1.  Generic and therapeutic substitutions: are they always ethical in their own terms?

Authors:  Mubarak AlAmeri; Miran Epstein; Atholl Johnston
Journal:  Pharm World Sci       Date:  2010-12

2.  The cost effectiveness of statin therapies in Spain in 2010, after the introduction of generics and reference prices.

Authors:  Pedro Plans-Rubió
Journal:  Am J Cardiovasc Drugs       Date:  2010       Impact factor: 3.571

Review 3.  Increasing generic drug use in Medicare Part D: the role of government.

Authors:  Herb Kohl; William H Shrank
Journal:  J Am Geriatr Soc       Date:  2007-07       Impact factor: 5.562

4.  Comparing generic and innovator drugs: a review of 12 years of bioequivalence data from the United States Food and Drug Administration.

Authors:  Barbara M Davit; Patrick E Nwakama; Gary J Buehler; Dale P Conner; Sam H Haidar; Devvrat T Patel; Yongsheng Yang; Lawrence X Yu; Janet Woodcock
Journal:  Ann Pharmacother       Date:  2009-09-23       Impact factor: 3.154

5.  Refilling and switching of antiepileptic drugs and seizure-related events.

Authors:  J J Gagne; J Avorn; W H Shrank; S Schneeweiss
Journal:  Clin Pharmacol Ther       Date:  2010-07-14       Impact factor: 6.875

Review 6.  Seizure outcomes following the use of generic versus brand-name antiepileptic drugs: a systematic review and meta-analysis.

Authors:  Aaron S Kesselheim; Margaret R Stedman; Ellen J Bubrick; Joshua J Gagne; Alexander S Misono; Joy L Lee; M Alan Brookhart; Jerry Avorn; William H Shrank
Journal:  Drugs       Date:  2010-03-26       Impact factor: 9.546
  6 in total
  4 in total

1.  Generic and therapeutic substitution: a response to our critic.

Authors:  Mubarak Nasser Al Ameri; Miran Epstein; Atholl Johnston
Journal:  Int J Clin Pharm       Date:  2011-09-17

2.  The differences between the branded and generic medicines using solid dosage forms: In-vitro dissolution testing.

Authors:  Mubarak Nasser Al Ameri; Nanda Nayuni; K G Anil Kumar; David Perrett; Arthur Tucker; Atholl Johnston
Journal:  Results Pharma Sci       Date:  2011-12-07

Review 3.  A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study.

Authors:  Suzanne Dunne; Bill Shannon; Colum Dunne; Walter Cullen
Journal:  BMC Pharmacol Toxicol       Date:  2013-01-05       Impact factor: 2.483

4.  Representative sample survey on factors determining the Czech physicians' awareness of generic drugs and substitution.

Authors:  J Maly; E Zimcikova; J Babica; A A Kubena; J Kostriba; K Mala-Ladova
Journal:  BMC Health Serv Res       Date:  2019-10-30       Impact factor: 2.655
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.